Dr. Reddy's launches immuno-oncology drug Toripalimab in India for nasopharyngeal carcinoma, expanding access to innovative treatment.

Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal carcinoma (NPC) -- a rare and aggressive form of head and neck cancer that...